Cargando…
Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes
Liraglutide is a glucagon-like peptide-1 receptor agonist used as a treatment for type 2 diabetes mellitus, which has been expanded for use at a higher dose in weight control. Therefore, it is necessary to consider adverse reactions of the drug at high doses as well as at lower doses after the indic...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for the Study of Obesity
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017323/ https://www.ncbi.nlm.nih.gov/pubmed/33071241 http://dx.doi.org/10.7570/jomes20059 |